z-logo
open-access-imgOpen Access
A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial for Adult Evaluation of the Efficacy and Safety of a Sars-Cov-2 Recombinant Spike Rbd Protein Vaccine (Abdala-3 Study)
Author(s) -
Francisco Hernández-Bernal,
Maria del Carmen Ricardo-Cobas,
Yenima Martín-Bauta,
Ernesto Rodríguez-Martínez,
Klaudia Urrutia-Pérez,
Karen Urrutia-Pérez,
Joel Quintana-Guerra,
Zadis Navarro-Rodríguez,
Marjoris Piñera-Martínez,
José L. Rodríguez-Reinoso,
Cristina Olimpia Chávez-Chong,
Idania Baladrón-Castrillo,
Grettel Melo-Suárez,
Alejandro Batista-Izquierdo,
Alexis R. Pupo-Micó,
Ricardo L. Mora-Betancourt,
Dayamí Soler-Cano,
Jacqueline Bizet-Almeida,
Maria C. Martínez-Rodríguez,
Leonardo Lobaina-Lambert,
Vivian M. Velázquez-Pérez,
Jalimy Soler-Díaz,
Yunaili Blanco-Garrido,
Sandra Laurencio-Vallina,
Tamara Meriño-Hechavarría,
Norberto Carmenaty-Campos,
Enri Rodríguez-Montero,
Miladys Limonta-Fernández,
Marel A. Valdés,
Reinier Hernández-Rodríguez,
Eulogio Pimentel-Vázquez,
Karem M. Catasús-Álvarez,
Maria V. Cabrera-Núñez,
Marta Ayala-Ávila,
Verena L. Muzio-González,
ABDALA Group of Investigators
Publication year - 2022
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.4213351
Subject(s) - placebo , medicine , recombinant dna , clinical trial , double blind , vaccine trial , spike (software development) , virology , covid-19 , biology , pathology , genetics , alternative medicine , disease , computer science , infectious disease (medical specialty) , software engineering , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom